Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
perifosine
.
Show all posts
Showing posts with label
perifosine
.
Show all posts
Thursday, August 30, 2012
Keryx Biopharmaceuticals Announces Top-Line Data from the Perifosine (KRX-0401) X-PECT Phase 3 Clinical Trial
›
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" ( X eloda ® + P erifosine E valuation in C olorectal ...
Wednesday, August 29, 2012
Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC
›
RESULTS: In the Perifosine 228 trial, 1 patient achieved a partial response (objective response rate, 4%; 95% confidence interval, ...
›
Home
View web version
